The key takeaway is that under normal usedrawing from an aluminum-covered vial into a transparent syringe and injecting within a minute or sothere is nothing to worry about
The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]
Without such trials, it is not possible to definitively establish what dose BPC-157 do in the human body, what an appropriate human research framework would look like, what the human safety profile is, or what conditions if any it might effectively address in clinical practice
From a scientific discussion perspective , BPC-157 is of interest due to its stability and the research questions it raises
mechanisms proposed include NO modulation and angiogenesis